In addition to Leqembi, Biogen’s postpartum depression drug Zurzuvae generated $12 million in quarterly revenues, topping the $2 million it brought in last quarter.
Novartis raises guidance following strong Q1 earnings
Some of the top growth drivers for Novartis included Entresto, which generated $1.8 billion in sales as well as Cosentyx, which generated $1.3 billion.
Abbott beats Wall Street expectations with med device sales, raises outlook
Looking at the year ahead, Haleon projected organic revenue growth between 4% to 6% as well as organic operating profit growth exceeding organic revenue growth.